Navigation Links
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
Date:8/8/2011

3 million in license fees received in 2011 for the out-licensing of patent technology related to Insmed's CISPLATIN Lipid Complex.

Research and development (R&D) expenses were $8.7 million for the second quarter of 2011, compared to $0.9 million in the second quarter of 2010.  The increase of $7.8 million is attributable to the full scale R&D activities for Arikace™, including the preparation for the initiation of the phase 3 clinical studies planned for the second half of 2011, and the manufacturing of supply to support the studies.  General and administrative (G&A) expenses were $2.7 million for the second quarter of 2011, compared to $1.9 million for the same period in 2010.  The $0.8 million increase was primarily attributable to the increased headcount associated with the administrative support for the full-scale development of Arikace™.

Research and development expenses increased to $14.5 million in the six-months ended June 30, 2011 from $1.5 million for the six-months ended June 30, 2010.  The increase of $13.0 million in 2011 is also attributable to full scale R&D of Arikace™, including the preparation of the phase 3 studies planned for the second half of 2011 and the manufacturing of supply to support the studies.  Of note within the R&D expenses, clinical development and regulatory expenses increased $6.6 million for the first six-months of 2011 compared to 2010 as a result of the planning efforts for the two phase 3 CF studies and one phase 3 NTM study.  There was also a $3.0 million increase in clinical manufacturing expenses from 2011 to 2010 attributable to the manufacturing of Arikace™ for use in the phase 3 studies while compensation expenses rose $2.4 million due to an increased headcount of 12 year on year, and additionally we incurred the final $1.0 million payment for the recently completed rat carcinogenicity study.  G&A expenses increase
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
7. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
9. Insmed to Host Third Quarter 2010 Conference Call
10. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
11. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , Sept. 12, 2014 /PRNewswire-iReach/ -- 9 th ... 22-24, 2014 – Bethesda, MD ... http://www.fdanews.com/9thInspectionsSummitEarlyBird   Photo - http://photos.prnewswire.com/prnh/20140912/145652 ... for the next inspection than to get a glimpse ... during and after an inspection. Come to ...
(Date:9/12/2014)... 12, 2014  Lakeland Industries, Inc. (NASDAQ: ... industrial protective clothing for industry, municipalities, healthcare and ... local levels, today announced the global availability of ... Ebola virus.  In response to the increasing demand ... healthcare workers and others being exposed to Ebola, ...
(Date:9/12/2014)... , September 12, 2014 ... by Products (Glucose Monitoring & Infectious Diseases Testing Kits, ... Professional Monitoring), Over the Counter & Prescription Based - ... the global POC Diagnostics Market over the forecast period ... grow at a CAGR of 9.3% from 2013 to ...
Breaking Medicine Technology:FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Lakeland Industries Announces Global Availability of Hazmat Suits for Ebola 2Lakeland Industries Announces Global Availability of Hazmat Suits for Ebola 3Lakeland Industries Announces Global Availability of Hazmat Suits for Ebola 4Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
... Sept. 29, 2011 The U.S. Food and Drug ... the International Internet Week of Action (IIWA), a cooperative ... and illegal medical products. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... between Sept. 20 and Sept. 27 is called OPERATION ...
... Sept. 29, 2011 CIVCO ... installed at the Instituto Radioterapia del Este in Puerto ... the Protura system elevates the level of radiation therapy ... need for many patients to travel for treatment. ...
Cached Medicine Technology:FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 2FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 3FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 4CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 2CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 3
(Date:9/14/2014)... AURORA, Colo. (PRWEB) September 14, 2014 ... growth and metastasis in several human cancers including pancreatic, ... its activity are not available. A study published today ... target the activation of these Ral proteins: "When you ... can tie its mouth shut. We took another approach ...
(Date:9/14/2014)... York (PRWEB) September 14, 2014 ... to move forward in courts throughout the U.S., ... filed in San Francisco Superior Court, defendants in ... the judge overseeing the proceeding to deny a ... re-transferred to Los Angeles Superior Court. Plaintiffs seeking ...
(Date:9/14/2014)... September 14, 2014 Transvaginal mesh ( ... New Jersey, where two separate litigations are moving forward ... , According to Case Lists updated on September ... devices marketed by C.R. Bard Inc., and Johnson & ... against C.R. Bard, a total of 1,557 claims have ...
(Date:9/14/2014)... OH (PRWEB) September 14, 2014 A new ... & Schulte LLC on behalf of a Franklin County, ... metal-on-metal hip implant. The metal-on-metal hip lawsuit filed against ... that the Ohio man was 40 years old when the ... (Case No. 3:14-cv-02428-K) According to the hip implant ...
(Date:9/14/2014)... UWDress.com, is an internationally well-known designer and ... its new range of cocktail dresses under $100 ... to worldwide ladies, the company is also providing big ... blue evening gowns, black formal gowns and so on. ... , The company’s senior spokesman says, “We are ...
Breaking Medicine News(10 mins):Health News:Nature: New drug blocks gene driving cancer growth 2Health News:Nature: New drug blocks gene driving cancer growth 3Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 3Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 4Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 2Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 3Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2
... cancer (CRC) is the third leading cause of cancer ... of people who need CRC screening receive it. The ... patients about the importance of screening and to encourage ... CRC. Recognizing that those without insurance have ...
... preparation (ICCBco) in the treatment of lung lesions ... experimental animal model, a research group in China ... pathological changes and pathological effect mechanism of expression ... of portal hypertensive rabbits with schistosomiasis. ...
... risk, but elderly women are too, study finds , THURSDAY, ... cause of shoulder dislocation, and young males have the highest ... shows. , Researchers studied 8,940 shoulder dislocations treated at 100 ... 2006 and found that the overall incidence rate was 23.9 ...
... ... MD, MPH, to determine whether they are allergic to penicillin. In years past, this was ... new product called Pre-Pen in his office, and is available for testing. , ... (PRWEB) March 4, 2010 -- Patients with ...
... ... ... , ... , , ...
... ... ... ... ...
Cached Medicine News:Health News:Physicians come together on National Colorectal Cancer Awareness and Screening Day 2Health News:Treatment of portal hypertensive pulmonary lesions induced by schistosomiasis 2Health News:Shoulder Dislocations a Sports Hazard 2Health News:New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care 2Health News:Cymetrix Board Member Recognized for Enhancing the Growth and Operations of the Companies He Advises 2Health News:Cymetrix Board Member Recognized for Enhancing the Growth and Operations of the Companies He Advises 3Health News:Cymetrix Board Member Recognized for Enhancing the Growth and Operations of the Companies He Advises 4Health News:Thyroid Disease: The Hidden Epidemic 2Health News:Thyroid Disease: The Hidden Epidemic 3Health News:Thyroid Disease: The Hidden Epidemic 4
20 g MVR knife. Dimensions: 31.8 mm x 1.18 mm x 2.7 mm....
Full Handle Laseredge Spoon Blade Knife, 3.0 mm angled double bevel. Blade dimension: 11.0 mm (L) x 3.0 mm (W). Cut: 320....
Full Handle Laseredge Slit Blade Knife, 3.2 mm angled double bevel. Blade tip dimension: 14.4 mm x 3.2 mm x 4.0 mm....
Full Handle Laseredge Slit Blade Knife, 3.0 mm angled bevel up. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Medicine Products: